Creating First in Class Multispecific Antibody Modalities

The bispecific antibodies stream at the PEGS Summit will take you through a review of constructs, to the engineering and platform development all the way to preclinical and clinical data. Newer platforms, innovative approaches and constructs are combining to yield unprecedented efficacy. Don’t miss the most significant forum of the year to hear about new advances in the industry and meet face to face with leaders changing the future of biologics. 

Conferences and Training Seminars Include:

May 15-16

Introduction to Bispecific Antibodies

May 16-17

Advancing Bispecific Antibodies and Combination Therapy to the Clinic

May 18-19

Engineering Bispecific Antibodies

Keynote Presentations:

Triggered Bispecifics
JoAnn A. Suzich, PhD, Head, Research, Immunocore LLC

Antibody-Cytokine Fusions for the Treatment of Difficult-to-Cure Cancer Types: Emerging Clinical Results
Dario Neri, PhD, CEO and CSO, Philogen

2026 PROGRAMS

View By:

• Display of Biologics
• Engineering Antibodies
• Machine Learning for Protein Engineering

• Antibodies for Cancer Therapy
• Emerging Targets for Oncology & Beyond
• Driving Clinical Success in Antibody-Drug Conjugates

• TS: Intro to Multispecific Antibodies
• Advancing Multispecific Antibodies
• Engineering Bispecific and Multispecific Antibodies

• Emerging T Cell Engagers
• Advances in Immunotherapy
• Next-Generation Immunotherapies

• Difficult-to-Express Proteins
• Optimizing Protein Expression
• Maximizing Protein Production Workflows

• ML and Digital Integration in Biotherapeutic Analytics
• Biophysical Methods
• Characterization for Novel Biotherapeutics

• TS: Intro to Immunogenicity
• Predicting Immunogenicity with AI/ML Tools
• TS: Bioassay Development and Analysis

• Biologics for Autoimmune Diseases
• Frontiers in Radiopharmaceutical Therapy
• Emerging Peptide Therapeutics

• ML and Digital Integration in Biotherapeutic Analytics
• Predicting Immunogenicity with AI/ML Tools
• Machine Learning for Protein Engineering